Effect of pre-procedural statin therapy on myocardial no-reflow following percutaneous coronary intervention: a meta analysis.

TitleEffect of pre-procedural statin therapy on myocardial no-reflow following percutaneous coronary intervention: a meta analysis.
Publication TypeJournal Article
Year of Publication2013
AuthorsLi X-D, Yang Y-J, Hao Y-C, Yang Y, Zhao J-L, Dou K-F, Gu D-F
JournalChinese medical journal
Volume126
Issue9
Pagination1755-60
Date Published2013
Abstract

Successful revascularization of coronary artery disease, especially ST-elevation myocardial infarction (STEMI), does not always mean optimal myocardial reperfusion in a portion of patients because of no-reflow phenomenon. We hypothesized that statins might attenuate the incidence of myocardial no-reflow when used before percutaneous coronary intervention (PCI). The purpose of this study was to summarize the evidence of pre-procedural statin therapy to reduce myocardial no-reflow after PCI.

DOI10.4103/0974-2077.118423
Alternate JournalChin. Med. J.